An autoimmune "attack" on melanocytes triggers psoriasis and cellular hyperplasia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed.

1. Immunopeptidome analysis reveals SERPINB3 as an autoantigen driving eczematized psoriasis.Science advances · 2025
   Article
2. The Therapeutic Potential of Extracellular Vesicles in Psoriasis Treatment: Mechanisms, Applications, and Prospects.International journal of molecular sciences · 2025
   Review
3. Implication of Immunobiological Function of Melanocytes in Dermatology.Clinical reviews in allergy & immunology · 2025
   Review
4. Update on the etiopathogenesis of psoriasis (Review).Experimental and therapeutic medicine · 2022
   Review
5. Purinergic Signaling and Inflammasome Activation in Psoriasis Pathogenesis.International journal of molecular sciences · 2021
   Review
6. Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities.Dermatology and therapy · 2021
   Review
7. LC-MS/MS analysis of lesional and normally looking psoriatic skin reveals significant changes in protein metabolism and RNA processing.PloS one · 2021
   Article
8. Evaluating the effect of rice (Oryza sativa L.: SRNC05053-6-2) crude extract on psoriasis using in vitro and in vivo models.Scientific reports · 2020
   Article
9. New Treatment Addressing the Pathogenesis of Psoriasis.International journal of molecular sciences · 2020
   Review
10. Pathogenesis of psoriasis in the "omic" era. Part II. Genetic, genomic and epigenetic changes in psoriasis.Postepy dermatologii i alergologii · 2020
    Review
11. Advances in Understanding the Immunological Pathways in Psoriasis.International journal of molecular sciences · 2019
    Review
12. Phenotypic changes of lymphocyte populations in psoriasiform dermatitis animal model.Experimental and therapeutic medicine · 2019
    Article
13. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.Clinical reviews in allergy & immunology · 2018
    Review
14. Relationship between human leukocyte antigen DRB1 and psoriasis in Iraqi patients.Saudi medical journal · 2018
    Article
15. Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment.Therapeutic advances in chronic disease · 2018
    Article
16. Scanning the Immunopathogenesis of Psoriasis.International journal of molecular sciences · 2018
    Review
17. Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes.Experimental dermatology · 2017
    Article
18. The role of IL-23 and the IL-23/TJournal of the European Academy of Dermatology and Venereology : JEADV · 2017
    Review
19. An Interesting Case of Co-Existence of Vitiligo and Psoriasis with Co-localization.Indian dermatology online journal
    Article

Corrections and comments

• Comment on
  Melanocyte antigen triggers autoimmunity in human psoriasis.2015

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as